249 related articles for article (PubMed ID: 20919644)
21. Nanotubes connecting B lymphocytes: High impact of differentiation-dependent lipid composition on their growth and mechanics.
Tóth EA; Oszvald Á; Péter M; Balogh G; Osteikoetxea-Molnár A; Bozó T; Szabó-Meleg E; Nyitrai M; Derényi I; Kellermayer M; Yamaji T; Hanada K; Vígh L; Matkó J
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):991-1000. PubMed ID: 28645851
[TBL] [Abstract][Full Text] [Related]
22. Physiology and pathophysiology of sphingolipid metabolism and signaling.
Huwiler A; Kolter T; Pfeilschifter J; Sandhoff K
Biochim Biophys Acta; 2000 May; 1485(2-3):63-99. PubMed ID: 10832090
[No Abstract] [Full Text] [Related]
23. p53 and regulation of bioactive sphingolipids.
Heffernan-Stroud LA; Obeid LM
Adv Enzyme Regul; 2011; 51(1):219-28. PubMed ID: 21035490
[TBL] [Abstract][Full Text] [Related]
24. Cholesterol, sphingolipids, and glycolipids: what do we know about their role in raft-like membranes?
Róg T; Vattulainen I
Chem Phys Lipids; 2014 Dec; 184():82-104. PubMed ID: 25444976
[TBL] [Abstract][Full Text] [Related]
25. Regulation of sphingolipid and glycosphingolipid metabolism during neuronal growth and development.
Futerman AH; Boldin SA; Brann AB; Pelled D; Meivar-Levy I; Zisling R
Biochem Soc Trans; 1999 Aug; 27(4):432-7. PubMed ID: 10917616
[No Abstract] [Full Text] [Related]
26. Sphingolipids in neurodegeneration.
Haughey NJ
Neuromolecular Med; 2010 Dec; 12(4):301-5. PubMed ID: 20737248
[TBL] [Abstract][Full Text] [Related]
27. Sphingolipid homeostasis in the web of metabolic routes.
Aguilera-Romero A; Gehin C; Riezman H
Biochim Biophys Acta; 2014 May; 1841(5):647-56. PubMed ID: 24184514
[TBL] [Abstract][Full Text] [Related]
28. Sphingolipid homeostasis in the endoplasmic reticulum and beyond.
Breslow DK
Cold Spring Harb Perspect Biol; 2013 Apr; 5(4):a013326. PubMed ID: 23545423
[TBL] [Abstract][Full Text] [Related]
29. Sphingolipids: membrane microdomains in brain development, function and neurological diseases.
Olsen ASB; Færgeman NJ
Open Biol; 2017 May; 7(5):. PubMed ID: 28566300
[TBL] [Abstract][Full Text] [Related]
30. Dihydroceramide desaturase 1, the gatekeeper of ceramide induced lipotoxicity.
Rodriguez-Cuenca S; Barbarroja N; Vidal-Puig A
Biochim Biophys Acta; 2015 Jan; 1851(1):40-50. PubMed ID: 25283058
[TBL] [Abstract][Full Text] [Related]
31. The sphingomyelin cycle: a prototypic sphingolipid signaling pathway.
Hannun YA; Bell RM
Adv Lipid Res; 1993; 25():27-41. PubMed ID: 8368151
[No Abstract] [Full Text] [Related]
32. Modulation of sphingolipid metabolism with calorie restriction enhances insulin action in skeletal muscle.
Obanda DN; Yu Y; Wang ZQ; Cefalu WT
J Nutr Biochem; 2015 Jul; 26(7):687-95. PubMed ID: 25771159
[TBL] [Abstract][Full Text] [Related]
33. Introduction: Enigmas of Sphingolipids.
Stiban J
Adv Exp Med Biol; 2019; 1159():1-3. PubMed ID: 31502196
[TBL] [Abstract][Full Text] [Related]
34. Sphingolipid breakdown products: anti-proliferative and tumor-suppressor lipids.
Hannun YA; Linardic CM
Biochim Biophys Acta; 1993 Dec; 1154(3-4):223-36. PubMed ID: 8280742
[TBL] [Abstract][Full Text] [Related]
35. A sphingolipid mechanism for behavioral extinction.
Huston JP; Kornhuber J; Mühle C; Japtok L; Komorowski M; Mattern C; Reichel M; Gulbins E; Kleuser B; Topic B; De Souza Silva MA; Müller CP
J Neurochem; 2016 May; 137(4):589-603. PubMed ID: 26788861
[TBL] [Abstract][Full Text] [Related]
36. The state of lipid rafts: from model membranes to cells.
Edidin M
Annu Rev Biophys Biomol Struct; 2003; 32():257-83. PubMed ID: 12543707
[TBL] [Abstract][Full Text] [Related]
37. GIPC: Glycosyl Inositol Phospho Ceramides, the major sphingolipids on earth.
Gronnier J; Germain V; Gouguet P; Cacas JL; Mongrand S
Plant Signal Behav; 2016; 11(4):e1152438. PubMed ID: 27074617
[TBL] [Abstract][Full Text] [Related]
38. Drug Development in the Field of Sphinogolipid Metabolism.
Qu Z; Zhou L
Adv Exp Med Biol; 2022; 1372():169-188. PubMed ID: 35503181
[TBL] [Abstract][Full Text] [Related]
39. Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease?
Katsel P; Li C; Haroutunian V
Neurochem Res; 2007; 32(4-5):845-56. PubMed ID: 17342407
[TBL] [Abstract][Full Text] [Related]
40. Molecular facets of sphingolipids: mediators of diseases.
Ozbayraktar FB; Ulgen KO
Biotechnol J; 2009 Jul; 4(7):1028-41. PubMed ID: 19579220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
